Taiwan Health Office Denies Compensation For Drug Used Off-Label
This article was originally published in PharmAsia News
Executive Summary
Taiwan's Department of Health is denying compensation to patients who had adverse reactions to an epilepsy drug prescribed by their physicians for off-label use